Generic placeholder image

Current Drug Safety


ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Nitrofurantoin Pulmonary Toxicity: Neglected Threat

Author(s): Emilia Hardak, Gidon Berger, Norberto Krivoy, Anna Solomonov and Mordechai Yigla

Volume 5 , Issue 2 , 2010

Page: [125 - 128] Pages: 4

DOI: 10.2174/157488610790936169

Price: $65


Nitrofurantoin lung toxicity was diagnosed among ten patients receiving 50 mg/day to prevent recurrent urinary tract infection. In six patients a symptomatic period of 3-36 months preceded the diagnosis. All but one patient, with irreversible lung injury at presentation recovered completely, five after drug discontinuation and four after steroids therapy. Large amount of data regarding unexpected, sometimes severe pulmonary toxicity during nitrofurantoin therapy should maintain a high index of suspicion for the drug usage among patients with non-resolving pulmonary symptoms. Alternatively, the use of other antimicrobial agents with a better risk-to-benefit ratio should be considered.

Keywords: Lung, nitrofurantoin, toxicity

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy